colorectal cancer
Structured Exercise Improves Survival in Stage II/III Colon Cancer
A structured exercise program after adjuvant chemotherapy in patients with high-risk stage II or III colon cancer ...
JUNE 18, 2025
FDA Approves Opdivo With Yervoy for Unresectable or Metastatic MSI-H or dMMR Colorectal Cancer
The FDA has approved Opdivo with Yervoy for unresectable or metastatic microsatellite instability−high or ...
APRIL 9, 2025
FDA Approves Lumakras With Vectibix for KRAS G12C–Mutated Colorectal Cancer
The FDA has approved Lumakras with Vectibix for adult patients with KRAS G12C–mutated metastatic colorectal ...
JANUARY 21, 2025
FDA Grants Accelerated Approval to Braftovi for Some Patients With Metastatic Colorectal Cancer
The FDA granted accelerated approval to Braftovi with cetuximab and mFOLFOX6 for patients with metastatic ...
JANUARY 2, 2025
FDA Approves Opdivo Qvantig for Subcutaneous Injection
The FDA approved nivolumab plus hyaluronidase-nvhy (Opdivo Qvantig, Bristol Myers Squibb) for subcutaneous ...
DECEMBER 30, 2024
FIT Reduces Deaths From Colorectal Cancer
Evidence is emerging for the power of fecal immunochemical testing to not only reduce colorectal cancer incidence ...
AUGUST 21, 2024
FDA Approves Fruzaqla in Refractory Metastatic Colorectal Cancer
The FDA approved Fruzaqla for adult patients with metastatic colorectal cancer who received certain prior ...
NOVEMBER 9, 2023
Progress in Digestive Tract Cancer Treatments Reported at Cancer Meeting
Four new trials presented at ASCO 2023 may help change the way several GI cancers are treated.
SEPTEMBER 22, 2023
Study Supports Shorter CRC Screening Intervals After Acute Diverticulitis
San Diego—After acute diverticulitis, patients have a twofold greater risk for colorectal cancer, and ...
JULY 22, 2022
Erbitux Every 2 Weeks as Effective as Weekly
Data from a recent analysis confirmed the efficacy of a regimen of 500 mg/m2 of cetuximab every two weeks ...
MAY 19, 2021
Deadly Delays in CRC Screening During COVID-19 Pandemic
Delays in colorectal cancer screenings during this year’s coronavirus pandemic will result in a 12% increase ...
NOVEMBER 12, 2020
Opdivo Receives New Indication for MSI-H or dMMR Colorectal Cancer
The FDA granted a new indication to Opdivo for the treatment of patients aged 12 years and older with mismatch ...
AUGUST 2, 2017